Sg3 Management, LLC Kempharm, Inc Call Options Transaction History

Sg3 Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $621,736 - $949,003	71,300 Added 198.06%	107,300 $1 Million
Q2 2021 Aug 16, 2021	SELL	$8.52 - $15.47 $1.29 Million - $2.34 Million	-151,100 Reduced 80.76%	36,000 $462,000
Q1 2021 May 17, 2021	BUY	$5.6 - $13.47 $1.05 Million - $2.52 Million	187,100 New	187,100 $1.72 Million

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.